Psychotherapy for Depressed or Anxious Adolescents With Cancer

Depression Clinical Trial

Official title: Open Trial of Behavioral Activation Therapy for Depressed or Anxious Adolescents With Cancer

Status Withdrawn

Clinical Trial Summary

At present, there are no established treatments for depression or anxiety in adolescents with cancer, creating an important clinical and research gap. Fortunately, there is now substantial evidence documenting the efficacy of psychotherapy in the treatment of depressed and anxious adolescents in the general population.

Clinical Trial Description

Despite the high prevalence of depression and anxiety in cancer patients, little is known about the efficacy of psychotherapy in depressed and anxious adolescents with cancer.

Behavioral activation therapy (BAT) is a brief, manualized therapy that has shown efficacy in the treatment of major depressive disorder (MDD) and generalized anxiety disorder (GAD) in several controlled trials patients, including adult cancer patients. The goal of this open label clinical trial is to obtain preliminary evidence of the efficacy of BAT(6 sessions) in a group of adolescent cancer patients with MDD, GAD or adjustment disorder with mood or anxiety features.

We will test the efficacy of BAT using the Multidimensional Anxiety Scale for Children at several time points of the treatment. ;

Study Design

Intervention Model: Single Group Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

• Anxiety
• Cancer
• Depression

• NCT number: NCT02232438
• Study type: Interventional
• Source: New York State Psychiatric Institute
• Status: Withdrawn
• Phase: N/A
• Start date: January 2015
• Completion date: December 2017